• 20 June, 2025

Cardinal Health closes China distribution business, divests it to Shanghai Pharma

February 2, 2018 | Friday | News

The sale includes Cardinal Health's pharmaceutical and medical products distribution business in China

Image credit- kwupenn.edu

Image credit- kwupenn.edu

Cardinal Health has announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding. The sale includes Cardinal Health's pharmaceutical and medical products distribution business in China. The divestiture does not include Cardinal Health's remaining businesses in China, including Cordis, its recently acquired Patient Recovery business, its medical sourcing team or other functions.

 The gross proceeds of the transaction are $1.2 billion; the net proceeds are approximately $800 million after adjusting for third party indebtedness, withholding taxes, and other transaction expenses and adjustments. Cardinal Health plans to provide more detail on this divestiture in connection with its second quarter earnings call scheduled for February 8, 2018.
 
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products, pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home.

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

   New User? Create Account

Podcast

Most Read

Survey Box

Is APAC's wave of regional biotech partnerships creating a boom?

× Please select an option to participate in the poll.
  View poll results   More polls